Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Bipolar Disorder01:30

Bipolar Disorder

1.4K
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
1.4K
Borderline Personality Disorder01:25

Borderline Personality Disorder

961
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
961
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

779
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
779
Personality Disorders: Schizotypal and Histrionic01:20

Personality Disorders: Schizotypal and Histrionic

957
Schizotypal personality disorder and histrionic personality disorder are two distinct psychological conditions classified under personality disorders, each characterized by unique behavioral patterns and social difficulties. Both disorders significantly affect interpersonal relationships and emotional well-being, leading to social isolation and frustration.
Schizotypal Personality Disorder: Eccentric Behavior and Social Withdrawal
Schizotypal personality disorder is marked by odd or eccentric...
957
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Panic Disorder01:27

Panic Disorder

1.1K
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
1.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Towards an Integrated Staging Model for Bipolar Disorders: An International Society for Bipolar Disorders (ISBD) Staging Task Force Consensus Report.

Bipolar disorders·2026
Same author

Brainwide Structural Markers of Familial and Clinical Risk for Bipolar Disorder in Youth.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026
Same author

Validation and Extension of a Risk Calculator to Predict Mood Recurrence in Young People with Bipolar Disorder.

medRxiv : the preprint server for health sciences·2026
Same author

Agreement between smartphone-based mobile sensing and actigraphy sleep metrics in young people with bipolar disorder.

medRxiv : the preprint server for health sciences·2026
Same author

Effective connectivity of implicit emotion processing in adolescent psychiatric inpatients: Dynamic causal modeling across bipolar disorder and other psychopathologies.

Journal of affective disorders·2026
Same author

A Critical Overview of the Validity of the Current Concept of Bipolar Disorder.

Journal of personalized medicine·2025
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
関連記事をすべて見る

関連する実験動画

Updated: Apr 3, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.7K

双極性障害

Iria Grande1, Michael Berk2, Boris Birmaher3

  • 1Bipolar Disorders Unit, Clinical Institute of Neurosciences, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.

Lancet (London, England)
|September 22, 2015
PubMed
まとめ
この要約は機械生成です。

双極性障害は世界全体の 1%以上に影響を与え 障害や死亡率を引き起こします 診断上の課題とバイオマーカーの欠如のために,低狂気のエピソードに焦点を当てた臨床評価は,正確な診断に不可欠です.

さらに関連する動画

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.7K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

10.2K

関連する実験動画

Last Updated: Apr 3, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

1.7K
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.7K
Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders
08:33

Olfactory Neurons Obtained through Nasal Biopsy Combined with Laser-Capture Microdissection: A Potential Approach to Study Treatment Response in Mental Disorders

Published on: December 4, 2014

10.2K

科学分野:

  • 精神科 と 精神 保健
  • 神経科学
  • 臨床医学

背景:

  • 双極性障害は慢性的な再発性気分障害で 世界人口の1%以上に影響します
  • 認知障害,機能的欠陥,自殺を含む死亡率の増加と関連して,若い成人の障害の主な原因です.
  • 双極性障害の患者に高い割合の精神疾患や併発性疾患が共通している.

研究 の 目的:

  • 双極性障害を特定する際の診断上の課題を強調し,特に単極性うつ病と区別する.
  • 正確な診断において,低狂気のエピソードと縦断的な評価の検出を含む臨床評価の重要な役割を強調する.
  • 双極性障害の現在の薬理学的および心理学的治療戦略を理解することの重要性を強調する.

主な方法:

  • 双極性障害の臨床表現と診断基準のレビュー
  • 流行と影響に関する疫学データの分析
  • 現在の診断課題と臨床評価の役割の検討
  • 既存の治療方法と 進化する治療方法の議論

主要な成果:

  • 正確な診断はしばしば遅れます 双極性障害は一般的にうつ病のエピソードで,単極性うつ病を模倣します
  • 検証されたバイオマーカーがないため,徹底した臨床評価が必要である.
  • 長期的評価と低狂気期の識別は,差異診断に不可欠です.

結論:

  • 縦断的な追跡とヒポマニアの検出を含む臨床的評価は,双極性障害の診断に極めて重要です.
  • 有効なバイオマーカーに関するさらなる研究が必要である.
  • この複雑な状態の管理には 進化する治療戦略の認識と適用が不可欠です